Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies.

NCT01287988 is registered in ClinicalTrials.gov with ThromboGenics as lead sponsor.

NCT NCT01287988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies.
Lead sponsor
ThromboGenics
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
October 31, 2011
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic vitreomacular adhesion